Key points are not available for this paper at this time.
Lenvatinib与程序性细胞死亡蛋白1（PD-1）抑制剂的联合治疗在不可切除肝细胞癌中显示出显著疗效。本研究旨在评估包括肝动脉灌注化疗、Lenvatinib和PD-1抑制剂的三联疗法在治疗不可切除肝细胞癌中的安全性和有效性。
Building similarity graph...
Analyzing shared references across papers
Loading...
Zhenhua Bai
Xianhuan Yu
Qibin Tang
British Journal of Hospital Medicine
Sun Yat-sen University
Sun Yat-sen Memorial Hospital
Building similarity graph...
Analyzing shared references across papers
Loading...
Bai 等人（星期二）研究了该问题。
www.synapsesocial.com/papers/68e6023bb6db6435875959f2 — DOI: https://doi.org/10.12968/hmed.2024.0159